Genzyme

ALDURAZYME

Manufacturer:

Genzyme

Aldurazyme HCPCS:

J1931

HCPCS Code Descriptor:

Injection, laronidase, 0.1 mg

Category:

J Code

Aldurazyme NDCs:

58468-0070-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Aldurazyme CPT Codes:

Potential CPT administration codes for Aldurazyme can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Aldurazyme:

ALDURAZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J1931 is aligned to the drug ALDURAZYME.

ACCESS PRICING AND MORE BY REGISTERING

J1931 Added Date:

January 1, 2005

J1931 Effective Date:

January 1, 2005

J1931 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aldurazyme billing and coding information.
Aldurazyme patient assistance information can be found through Sanofi at the URL: https://www.sanofi.us/en/products-and-resources/patient-services/aldurazyme-laronidase-support
ALDURAZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ALDURAZYME. Please check back in a few weeks.